CJC-1295 without DAC is a synthetic peptide supplied exclusively for controlled laboratory research. The no-DAC designation identifies a peptide construct without Drug Affinity Complex modification.
In laboratory settings, CJC-1295 without DAC may be examined in assays involving growth hormone-releasing hormone receptor interactions, pituitary signaling, GH-axis measurements, ligand-receptor activity, and time-dependent endocrine research models.
Each vial contains 5mg of lyophilized peptide material. NordSci provides independent third-party analytical testing and lot-specific Certificate of Analysis documentation for identity and purity verification.
| Specification | Product Information |
|---|---|
| Product Name | CJC-1295 without DAC |
| Unit Size | 5mg per vial |
| Unit Quantity | 1 vial |
| Peptide Class | GHRH analog |
| Form | Lyophilized powder |
| Appearance | White powder |
| Source | Chemical synthesis |
| Purity (HPLC) | >99% |
| Testing | Independent third-party analytical testing |
| Documentation | Lot-specific COA available |
The primary concern for peptide researchers today is product purity. Nord-sci guarantees our product purity by performing independent testing of our products and providing those certifications for our customers in our product descriptions.
THIS PRODUCT IS NOT INTENDED TO TREAT, CURE OR DIAGNOSE ANY CONDITION OR DISEASE AND IS NOT FOR HUMAN CONSUMPTION. ALL PRODUCTS OFFERED ARE INTENDED FOR LABORATORY RESEARCH USE ONLY.
All products are produced using lyophilization (freeze-drying), a preservation method that allows peptides to remain fully stable during shipping for approximately 3-4 months. Once a peptide has been reconstituted with bacteriostatic water, it must be refrigerated to maintain integrity. After reconstitution, peptides typically remain stable for up to 30 days when stored properly.
Lyophilization, also referred to as cryodesiccation, is a specialized dehydration process in which peptides are first frozen and then exposed to a low-pressure environment. This causes the water within the vial to transition directly from a solid to a vapor (sublimation), leaving behind a dry, crystalline white material known as a lyophilized peptide. In this powdered form, peptides may be safely stored at room temperature until they are ready to be reconstituted with bacteriostatic water.
After delivery, peptides should be protected from heat and light. If use is expected within the near future (whether days, weeks, or a few months) refrigerated storage below 4°C (39°F) is generally sufficient. Lyophilized peptides are commonly stable at room temperature for several weeks or longer, making short-term ambient storage acceptable when use is anticipated within that timeframe.
For extended storage, ranging from several months to multiple years, freezing is strongly recommended. Storage at -80°C (-112°F) offers optimal long-term stability and helps preserve peptide structure and quality over time.
For more detailed guidance on peptide handling and storage best practices, please refer to the resource below:
CJC-1295 without DAC is a synthetic growth hormone-releasing hormone analog manufactured exclusively for controlled laboratory research. The “without DAC” designation indicates that the peptide does not contain the Drug Affinity Complex modification associated with certain extended-duration research constructs.
Laboratories may examine CJC-1295 without DAC in controlled in vitro assays involving GHRH-receptor interactions, pituitary signaling systems, GH-axis measurements, ligand-binding characteristics, and time-dependent biochemical analysis. Each 5mg vial is supplied as a lyophilized powder and undergoes independent third-party analytical testing.
CJC-1295 (without DAC) Research Peptide Specifications:
| Product Name | CJC-1295 without DAC |
| Unit Size | 5mg per vial |
| Unit Quantity | 1 vial |
| Purity (HPLC) | >99% |
| Peptide Class | GHRH analog |
| Modification | Without Drug Affinity Complex |
| Appearance | Lyophilized white powder |
| Source | Chemical synthesis |
| Testing | Independent third-party analytical testing |
| Documentation | Lot-specific Certificate of Analysis available |
| Storage Conditions | Store lyophilized material at −20°C or below in a dry, dark environment. Protect from light, heat, and moisture. |
| Research Use Only | For in vitro laboratory research only. Not for human or animal consumption, veterinary use, clinical use, or therapeutic applications. |
CJC-1295 without DAC is a synthetic peptide analog associated with laboratory investigation of growth hormone-releasing hormone receptor biology. Research involving this material may examine peptide-receptor binding, signaling kinetics, assay timing, and controlled analytical measurements within GH-axis laboratory models.
The absence of a Drug Affinity Complex distinguishes this material from DAC-modified constructs. This structural distinction may be relevant when comparing peptide configurations, receptor-binding characteristics, analytical persistence, or time-dependent assay data.
CJC-1295 without DAC should be evaluated only through validated experimental systems operated by qualified laboratory personnel. Test conditions, controls, analytical methods, and acceptance criteria should be documented before experimental work begins.
Important Research Notice: NordSci peptides undergo independent third-party analytical testing using high-performance liquid chromatography and mass spectrometry. Lot-specific Certificate of Analysis documentation is available for identity review, purity verification, quality-control records, and internal laboratory audits.
THIS PRODUCT IS INTENDED EXCLUSIVELY FOR IN VITRO LABORATORY RESEARCH. NOT FOR HUMAN OR ANIMAL CONSUMPTION. NOT FOR VETERINARY, DIAGNOSTIC, THERAPEUTIC, FOOD, COSMETIC, OR DIETARY-SUPPLEMENT USE.
CJC-1295 without DAC may be included in controlled assays examining GHRH-receptor activity, ligand-receptor interactions, pituitary signaling variables, sampling intervals, and time-dependent GH-axis measurements.
Research designs may compare untreated controls, reference materials, and predefined test conditions. Assay format, analytical methods, environmental controls, sample timing, and acceptance criteria should be documented within the laboratory protocol.
Laboratory studies may evaluate relationships between GHRH-receptor signaling and downstream GH- or IGF-related analytical markers. Experimental measurements may include receptor-expression data, binding-protein measurements, biochemical markers, and time-sequenced sample analysis.
Separate control and comparator groups may be used to distinguish material-specific observations from background assay variability. Endpoint selection and data interpretation should follow the laboratory’s approved protocol and statistical plan.
Within controlled laboratory research, CJC-1295 without DAC may be examined as an upstream component of GH-axis signaling models. Work in this category should remain limited to predefined biochemical measurements, receptor activity, analytical timing, and model-specific data collection.
This material is not intended for consumer, clinical, performance, or body-composition applications. Laboratory research descriptions should not be interpreted as claims regarding human or animal outcomes.
Laboratories conducting multi-compound research may include CJC-1295 without DAC in staged experimental designs. A structured study may begin with baseline controls and individual-compound assay groups before advancing to multi-compound comparisons.
This methodology allows analytical variables to be documented separately and limits confounding inputs. Each material should be independently identified, tested, recorded, and evaluated according to the laboratory’s approved protocol.
Laboratory Protocol Requirements:
Experimental concentration, diluent selection, assay format, exposure period, sampling schedule, and analytical method must be established by qualified laboratory personnel. These parameters should be based on validated procedures, peer-reviewed laboratory methodology, and applicable institutional requirements.
This product page does not provide dosing, administration, injection, or in vivo application instructions. Laboratory personnel are responsible for establishing appropriate preparation, handling, storage, analytical-control, and disposal procedures.
All work involving CJC-1295 without DAC must be performed by qualified personnel in an appropriately equipped laboratory and in accordance with applicable institutional policies and regulations.
Each lot of CJC-1295 without DAC is accompanied by analytical documentation identifying the tested batch and reported purity. Available testing documentation may include:
COA records may be retained with procurement files, laboratory material logs, quality-control documentation, and internal audit records.
NordSci Peptides supplies CJC-1295 without DAC in 5mg vials for qualified laboratory and institutional research procurement. Product documentation includes labeling, storage information, analytical testing data, and lot-specific COA access.
IMPORTANT: CJC-1295 without DAC is sold exclusively as an in vitro laboratory research material. It is not approved for human use, animal consumption, veterinary applications, diagnostic procedures, therapeutic applications, food production, cosmetics, or dietary supplements.
